Report: DEA Dubious About Cannabis Rescheduling
Tue / Mar 12th
The Drug Enforcement Agency (DEA) is a federal law enforcement agency whose main job is to halt drug trafficking and distribution. Their focus on cannabis has become increasingly questionable as legal recreational use takes the world by storm. Articles including the DEA can be found here:
Tue / Mar 12th
Wed / Jan 31st
Twelve Senate Democrats have urged the Biden Administration to remove cannabis from the Controlled Substances Act, countering a recent HHS recommendation for Schedule III that is currently being reviewed by the DEA.
Thu / Jan 4th
Is the DEA planning to change the scheduling status of cannabis under the Controlled Substances Act? In a leaked letter to Congress, the agency has asserted their control over any decision about rescheduling or descheduling the plant.
Mon / Dec 11th
After Georgia made it legal for pharmacies to dispense low-THC cannabis oils in October, the Drug Enforcement Administration has apparently sent warning letters to several pharmacies in the state.
Fri / Sep 22nd
Fourteen Republican lawmakers have sent a letter to DEA Administrator Anne Milgram, urging the agency to reject the recent Department of Health and Human Services recommendation to reclassify cannabis from Schedule I to Schedule III under federal law.
Thu / Aug 31st
In a letter to DEA Administrator Anne Milgram, U.S. Rep. Matt Gaetz (R-FL) asked why the agency has not taken steps to reconsider cannabis’ status as a Schedule I substance.
Wed / Aug 16th
A recently revealed letter confirms that the U.S. Drug Enforcement Administration considers delta-8 THC that has been synthesized from hemp-derived CBD — so, the vast majority of consumer delta-8 products — to be federally illegal.
Wed / Aug 2nd
Cannabis research company MMJ International Holdings is preparing a lawsuit against the Drug Enforcement Administration (DEA) for allegedly failing to follow federal law as it concerns the cultivation of pharmaceutical cannabis.
Tue / May 23rd
The Drug Enforcement Administration (DEA) appears to support considering synthetic cannabinoids that contain THC — including hemp-derived delta-8 THC — as controlled substances under federal law, according to a recent agency conference presentation.
Tue / Feb 14th
The DEA declared this week that novel cannabinoids including delta-9 and -8 THCO are illegal, even when sourced from federally legal hemp crops.
Fri / Oct 7th
DEA Museum historian Kasey Sease, Ph.D. admitted that the reasons for criminalizing drug use were based on racial, ethnic, and class prejudice.
Wed / Oct 5th
DEA pharmaceutical cannabis license-holder Biopharmaceutical Research Company has raised $20 million in its Series A funding round.
Thu / Sep 15th PODCAST
Shane Pennington is the New York-based counsel for Vicente Sederberg LLP, a national cannabis law firm that represents cannabis industry clients and works on state and local cannabis policy reform.
Tue / Jun 21st
The DEA reported an uptick in cannabis arrests and seizures for last year, marking the highest federal enforcement figures since 2011.
Thu / May 12th
Police arrested activists outside of the headquarters of the DEA as they protested the agency’s refusal to let terminally ill patients access experimental drugs like psilocybin and MDMA.
Tue / May 3rd
Maridose LLC, based in Florida, is close to obtaining DEA approval to cultivate cannabis for research purposes in Maine.
Wed / Apr 27th
While a recent DEA letter appeared to suggest that cannabis material containing less than 0.3% THC is federally legal under the 2018 Farm Bill, legal experts still caution against sending seeds, clones, and other byproducts by mail.
Mon / Apr 11th
The DEA will recognize cannabis seeds as legal products under the 2018 Farm Bill so long as the seeds themselves do not exceed the 0.3% THC limit.
Tue / Mar 15th
Two companies have accused the DEA of delaying the application process for bulk cannabis manufacturing in the production of cannabinoid-based pharmaceuticals.
Wed / Feb 9th
A U.S. House proposal is seeking to reform the 2018 Farm Bill by increasing THC limits in hemp products, removing DEA lab testing requirements, and eliminating drug-related licensing restrictions.
Fri / Jan 7th
Groff North America Hemplex and BRC, two cannabis cultivation firms, have harvested federally sanctioned cannabis for research purposes, ending a 50-year monopoly by the University of Mississippi.
Fri / Nov 5th
A recently surfaced letter by a high-ranking DEA official may have hinted that the agency considers delta-8 THC products synthesized from hemp extracts to be federally legal.
Mon / Oct 25th
A cannabis cash transport company is seeking the return of $166,000 that was seized by police in partnership with the DEA who said they had detected a “marijuana odor.”
Thu / Oct 21st
Bank of America suddenly canceled the account of cannabis research firm Scottsdale Research Institute despite being fully compliant with federal laws and operating with public DEA approval.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.